Loncastuximab Biosimilar - Anti-CD19 mAb - Research Grade, Chimeric, Monoclonal
Artikelnummer:
PTG-PX-TA1481-1MG
| Artikelname: |
Loncastuximab Biosimilar - Anti-CD19 mAb - Research Grade, Chimeric, Monoclonal |
| Artikelnummer: |
PTG-PX-TA1481-1MG |
| Hersteller Artikelnummer: |
PX-TA1481-1MG |
| Alternativnummer: |
PTG-PX-TA1481-1MG |
| Hersteller: |
ProteoGenix |
| Wirt: |
Chimeric |
| Kategorie: |
Antikörper |
| Spezies Reaktivität: |
Human |
| Alternative Synonym: |
Anti-CD19, ADCT-402, RB4v1.2-SG-3249, CAS: 1875032-68-0 |
| Klonalität: |
Monoclonal |
| UniProt: |
P15391 |
| Puffer: |
0.94mM Citric acid, 16.7mM Trisodium citrate dihydrate, 6.2% sucrose, pH 6.5,0.01% Tween 80 |
| Expression System: |
Eukaryotic expression |
| Target-Kategorie: |
CD19 |